314 related articles for article (PubMed ID: 30341928)
1. Multicenter Implementation of a Novel Management Protocol Increases the Outpatient Treatment of Pulmonary Embolism and Deep Vein Thrombosis.
Kabrhel C; Rosovsky R; Baugh C; Connors J; White B; Giordano N; Torrey J; Deadmon E; Parry BA; Hagan S; Zheng H
Acad Emerg Med; 2019 Jun; 26(6):657-669. PubMed ID: 30341928
[TBL] [Abstract][Full Text] [Related]
2. Immediate Discharge and Home Treatment With Rivaroxaban of Low-risk Venous Thromboembolism Diagnosed in Two U.S. Emergency Departments: A One-year Preplanned Analysis.
Beam DM; Kahler ZP; Kline JA
Acad Emerg Med; 2015 Jul; 22(7):788-95. PubMed ID: 26113241
[TBL] [Abstract][Full Text] [Related]
3. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban-treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding.
Kline JA; Jimenez D; Courtney DM; Ianus J; Cao L; Lensing AW; Prins MH; Wells PS
Acad Emerg Med; 2016 Feb; 23(2):144-50. PubMed ID: 26765080
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.
Frank B; Ariza L; Lamparter H; Grossmann V; Prochaska JH; Ullmann A; Kindler F; Weisser G; Walter U; Lackner KJ; Espinola-Klein C; Münzel T; Konstantinides SV; Wild PS;
BMJ Open; 2015 Jul; 5(7):e008157. PubMed ID: 26133379
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
7. The creation and implementation of an outpatient pulmonary embolism treatment protocol.
Kabrhel C; Rosovsky R; Baugh C; Parry BA; Deadmon E; Kreger C; Giordano N
Hosp Pract (1995); 2017 Aug; 45(3):123-129. PubMed ID: 28402686
[TBL] [Abstract][Full Text] [Related]
8. The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients.
Arcelus JI; Caprini JA; Monreal M; Suárez C; González-Fajardo J
J Vasc Surg; 2003 Nov; 38(5):916-22. PubMed ID: 14603194
[TBL] [Abstract][Full Text] [Related]
9. Cost of Treating Venous Thromboembolism With Heparin and Warfarin Versus Home Treatment With Rivaroxaban.
Kahler ZP; Beam DM; Kline JA
Acad Emerg Med; 2015 Jul; 22(7):796-802. PubMed ID: 26111453
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry.
Yamashita Y; Murata K; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Nawada R; Onodera T; Kimura T;
Thromb Res; 2019 Dec; 184():50-57. PubMed ID: 31706068
[TBL] [Abstract][Full Text] [Related]
11. Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.
LaMori JC; Shoheiber O; Mody SH; Bookhart BK
Clin Ther; 2015 Jan; 37(1):62-70. PubMed ID: 25524389
[TBL] [Abstract][Full Text] [Related]
12. A treatment strategy using subcutaneous fondaparinux followed by oral rivaroxaban is effective for treating acute venous thromboembolism.
Kabuki T; Nakanishi R; Hisatake S; Fujii T; Dobashi S; Wakakura S; Kiuchi S; Fujino T; Ikeda T
J Cardiol; 2017 Aug; 70(2):163-168. PubMed ID: 27979674
[TBL] [Abstract][Full Text] [Related]
13. Practical management of rivaroxaban for the treatment of venous thromboembolism.
Imberti D; Benedetti R
Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
[TBL] [Abstract][Full Text] [Related]
14. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
[TBL] [Abstract][Full Text] [Related]
15. Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.
Yhim HY; Choi WI; Kim SH; Nam SH; Kim KH; Mun YC; Oh D; Hwang HG; Lee KW; Song EK; Kwon YS; Bang SM
Korean J Intern Med; 2019 Sep; 34(5):1125-1135. PubMed ID: 29788694
[TBL] [Abstract][Full Text] [Related]
16. Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.
Al Sayegh F; Almahmeed W; Al Humood S; Marashi M; Bahr A; Al Mahdi H; Bakir S; Al Farhan M
Clin Appl Thromb Hemost; 2009; 15(3):289-96. PubMed ID: 18400764
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.
Khorana AA; Vadhan-Raj S; Kuderer NM; Wun T; Liebman H; Soff G; Belani C; O'Reilly EM; McBane R; Eikelboom J; Damaraju CV; Beyers K; Dietrich F; Kakkar AK; Riess H; Peixoto RD; Lyman GH
Thromb Haemost; 2017 Nov; 117(11):2135-2145. PubMed ID: 28933799
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in long-term outcomes of patients with deep vein thrombosis.
Chan SM; Brahmandam A; Valcarce-Aspegren M; Zhuo H; Zhang Y; Tonnessen BH; Lee AI; Ochoa Chaar CI
Vascular; 2023 Oct; 31(5):994-1002. PubMed ID: 35502988
[TBL] [Abstract][Full Text] [Related]
19. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
Ma G; Zhang R; Wu X; Wang D; Ying K
Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
[TBL] [Abstract][Full Text] [Related]
20. Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis.
Piran S; Le Gal G; Wells PS; Gandara E; Righini M; Rodger MA; Carrier M
Thromb Res; 2013 Nov; 132(5):515-9. PubMed ID: 24035045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
